Browse Articles
Discover research articles across all indexed journals
Influence of fractal fabric on the shear characteristics of large scale accumulation bodies
Alpha-globin gene cluster haplotypes and D1S80, D17S5, and TPO VNTR polymorphisms among four ethnic populations from lower northeastern Thailand
Could psychedelics be fine-tuned to relieve anxiety but skip the ‘trip’?
Evolutionary processes and drivers of agricultural functions in Chinese villages
Impact of high frequency electromagnetic radiation on bacterial survival and antibiotic activity in exposed bacteria
Abstract High-frequency electromagnetic waves (HFEMWs) have been shown to influence cellular functions, including bacterial behavior, potentially affecting growth and antibiotic sensitivity. This study evaluated the response of Escherichia coli and Staphylococcus aureus to HFEMWs across a frequency range of 900 MHz to 73 GHz. The Bacterial sensitivity to antibiotics, including ceftazidime, ceftaroline, gentamycin, doxycycline, and ciprofloxacin, was assessed. The growth rate was evaluated by measuring the optical density (OD) and the number of colony-forming units (CFUs). Our results revealed significant electromagnetic interference (EMI) effects at frequencies of 51.8 GHz and 53 GHz, with 53 GHz showing the most pronounced impact. These frequencies enhanced bacterial susceptibility, with previously resistant E. coli and S. aureus strains becoming sensitive to tested antibiotics. Conversely, 70.6 GHz and 73 GHz frequencies showed limited effects, while exposure to 900 MHz and 1800 MHz caused no notable changes. These findings highlight the frequency-dependent effects of HFEMWs on bacterial viability and antibiotic sensitivity. This research underscores the potential of HFEMWs as a complementary antimicrobial strategy, offering opportunities for improved infection control and innovative sterilization technologies to mitigate hospital-acquired infections.
Molecular glue unexpectedly mimics the effect of cancer mutations
Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients
Artificial intelligence could boost eye care in low-income countries
Empirical potential calculations of UO2 for a better understanding of its stringlike motion at high temperature
Hippocampal neuronal activity is aligned with action plans
Drivers of spring migration phenology in Rocky Mountain elk
Distinct assembly processes of intestinal and non-intestinal microbes of bark beetles from clues of metagenomic insights
Global lightning-ignited wildfires prediction and climate change projections based on explainable machine learning models
Analysis of power system transient stability with PSO-optimized distributed generation and HVDC transmission systems
Proposing a machine learning-based model for predicting nonreassuring fetal heart
How can treatment for eye disease be made easier?
SARS-CoV-2 evolution on a dynamic immune landscape
Abstract Since the onset of the pandemic, many SARS-CoV-2 variants have emerged, exhibiting substantial evolution in the virus’ spike protein 1 , the main target of neutralizing antibodies 2 . A plausible hypothesis proposes that the virus evolves to evade antibody-mediated neutralization (vaccine- or infection-induced) to maximize its ability to infect an immunologically experienced population 1,3 . Because viral infection induces neutralizing antibodies, viral evolution may thus navigate on a dynamic immune landscape that is shaped by local infection history. Here we developed a comprehensive mechanistic model, incorporating deep mutational scanning data 4,5 , antibody pharmacokinetics and regional genomic surveillance data, to predict the variant-specific relative number of susceptible individuals over time. We show that this quantity precisely matched historical variant dynamics, predicted future variant dynamics and explained global differences in variant dynamics. Our work strongly suggests that the ongoing pandemic continues to shape variant-specific population immunity, which determines a variant’s ability to transmit, thus defining variant fitness. The model can be applied to any region by utilizing local genomic surveillance data, allows contextualizing risk assessment of variants and provides information for vaccine design.
Inhibition of TGF-β signaling enhances osteogenic potential of iPSC-derived MSCs
Abstract Mesenchymal stem cells (MSCs) represent the most commonly utilized type of stem cell in clinical applications. However, variability in quality and quantity between different tissue sources and donors presents a significant challenge to their use. Induced pluripotent stem cells (iPSCs) are a promising and abundant alternative source of MSCs, offering a potential solution to the limitations of adult MSCs. Nevertheless, a standardized protocol for the differentiation of iPSCs into iPSC-derived mesenchymal stem cells (iMSCs) has yet to be established, as the existing methods vary significantly in terms of complexity, duration, and outcome. Many straightforward methods induce differentiation by culturing iPSCs in MSC media which are supplemented with fetal bovine serum (FBS) or human platelet lysate (hPL), followed by selection of MSC-like cells by passaging. However, in our hands, this approach yielded inconsistent quality of iMSCs, particularly in terms of osteogenic potential and premature senescence. This study examines the impact of the selective TGF-β inhibitor SB431542 on iMSC differentiation, demonstrating that TGF-β inhibition enhances osteogenic potential and reduces premature senescence. Additionally, we present a reliable, xeno-free method for producing high-quality iMSCs that can be adapted for Good Manufacturing Practice (GMP) compliance, thus enhancing the potential for clinical applications.